Skip to main content
Premium Trial:

Request an Annual Quote

Canon BioMedical's Novallele Genotyping Assays

Canon BioMedical has launched eleven new genotyping assays. The new assays complement the company's existing 32 assays that target important genes in the CYP family and are part of the 75 Novallele genotyping assays offered by the company that are able to detect variants relevant to pharmacogenetics research. The Novallele assays detect genetic variations using PCR followed by high-resolution melting (HRM) analysis on any thermocycler capable of HRM. The company noted that these assays can not only identify variations in the CYP family, but can also identify variations in the VKORC1, SLC6A4, and DPYD genes.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more